Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon Adds Two New Product Distributors

Premium

Exiqon said this week that it has added two new distribution partners to handle its life science products, including its locked nucleic acid-based reagents for microRNA research.

Speficially, Biomedica Medizinprodukte will market Exiqon's products in Czech Republic, Slovakia, Slovenia, Croatia, Bosnia and Herzegovina, Serbia, Montenegro, Macedonia, Kosovo, Albania, Poland, Hungary, Romania, and Bulgaria.

Biotik will distribute Exiqon products in Brazil.

Exiqon said its total distributor network now consists of 18 distributors covering South and Eastern Europe, Middle East, Brazil, Asia, and Australia/New Zealand.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.